Intron A is effective for treating ACUTE hepatitis C
There's a lot of excitement about the news that Intron A is effective for treating ACUTE hepatitis C.
Right now Intron A is approved for CHRONIC hep C.
But early treatment with Intron A can help eradicate the virus and prevent chronic infection.
Table of Contents
- prevent mix-ups due to drug names that sound or look alike
- Augmentin ES-600 for treating recurrent or persistent otitis media in children
- Intron A is effective for treating ACUTE hepatitis C
- appropriate use of inhaled steroids for treating persistent asthma
- NuvaRing, the first contraceptive vaginal ring
- Entocort EC, a new ORAL form of budesonide for Crohn's disease
- H. pylori infection increases the risk of gastric cancer
- Consumer Reports has just released their evaluation of blood glucose meters and lancets
- The Federal Aviation Administration (FAA) now has new security measures regarding syringe needles and lancets
- SSRIs can prevent heart attacks
- diphenhydramine decreases cognitive function in elderly patients
- Aranesp (darbepoetin alfa), the new longer-acting erythropoietin analog for anemia
- certain antioxidants and zinc can slow the progression of age-related macular degeneration
- Topamax might cause vision problems
- glucosamine might be causing elevated cholesterol and blood pressure
- Vitamin B12 deficiency can often be treated with ORAL supplements
- big push to avoid using Demerol (meperidine)
- drugs for bioterrorism (anthrax, etc)...a patient-handout version